Viridian Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -2.68 | -100% |
| P/S |
|
3201.3 | 33.76 | 9383.23% |
|
|
| P/BV |
|
2.27 | 4.82 | -52.83% |
|
|
| P/FCF |
|
-4.42 | 60.98 | -107.25% |
|
|
| Ev/Ebitda |
|
-3.92 | -22.12 | -82.26% |
|
|
| Ev/S |
|
2940.86 | 22.56 | 12933.86% |
|
|
| Ev/FCF |
|
-4.99 | 68.75 | -107.26% |
|
|
| E/P |
|
-0.2906 | 0.0178 | -1735% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-74957.01 | 4.83 | -1551887.14% | -17939.44 | 317.83% |
| ROE |
|
-53.78 | 9.61 | -659.88% |
|
|
| ROA |
|
-48.48 | 0.3359 | -14531.2% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-75711.46 | -25.17 | 300699.01% |
|
|
| ROCE |
|
-53.55 | 15.33 | -449.26% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0894 | -3.67 | -97.56% | -0.0475 | 88.4% |
| Nеt Debt/Ebitda |
|
0.3475 | -3.44 | -110.1% |
|
|
| Debt/Ratio |
|
0.0429 | 0.1972 | -78.23% |
|
|
| Debt/Equity |
|
16.19 | 1.65 | 883.38% |
|
|
| Debt/Net Income |
|
-0.0885 | 10.31 | -100.86% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-92.96 | -56.89 | 63.4% |
| Growth impulse Ebitda 5 years |
|
473.53 | -64.81 | -830.64% |
| Growth impulse Net Income 5 years |
|
471.68 | -58.33 | -908.64% |
| Growth impulse FCF 5 years |
|
412.09 | -47 | -976.79% |
| Growth impulse EPS 5 years |
|
-73.31 | -32.41 | 126.2% |
IP Score
3.5/10
